Global Normal Balloon Catheter Market: Global Outlook and Forecast Based on Upcoming Trends Analysis through 2022
Fact.MR has published a new
research report on global normal balloon catheter market sizes, upcoming
industry trends and growth opportunity through 2017-2022 to its online database
that tries to unveil the various scenarios prevailing in the normal
balloon catheter market. This assessment delivers a smart compilation
of primary and secondary data which provides a clear insight about the future
plans expected to impact the normal balloon catheter market. This study
comprises of prominent data which makes it a beneficial source for investors,
analysts and industry experts to acquire necessary knowledge associated to the
fundamental market trends, opportunities and growth drivers.
Normal balloon catheter, an
innovative medical device, comprises a catheter and a guidewire that is
inserted into femoral artery in the legs, or, sometimes into radial artery in
arms for treating constricted blood vessels. Generally normal balloon catheter
is utilized for preventing blood vessel constriction, which is caused by
atherosclerosis, i.e. deposition of the lipid substances in blood vessels. The
surge in interventional cardiology has been facilitating the utilization of
normal balloon catheters. Moreover, there is a rise in prevalence of patients
affected with the end stage renal disease. The number of patients seeking for
renal replacement therapy has also increased. Leading manufacturers of normal
balloon catheters are developing efficient and cost-effective solutions. These
incidences might influence growth of the global normal balloon catheter market
in the upcoming years. In contrast, costs of angioplasty procedures are very
high, coupled with the risks such as artery collapse and infection related to
balloon catheterization, which in turn will impede growth of the market.
The number of cardiovascular
diseases has been witnessing a rise, along with growing cases of cardiology
intervention procedures worldwide. Several governments are providing
reimbursement support for people suffering from vascular diseases. There has
also been a hike in healthcare expenditure. These factors might favor demand
for normal balloon catheters. In addition, various other factors such as
growing geriatric population, rising investments in research & development
activities concerning normal balloon catheters are expected to pave potential
growth opportunities for manufacturers of normal balloon catheters. The global
market for balloon catheter is likely to exhibit a moderate growth during 2017
to 2022. Revenues from the global market for normal balloon catheter will reach
nearly US$ 2,000 Mn by 2022-end.
In terms of revenues, Europe will
account for the largest share of the market during the forecast period. Europe
will continue to be the most lucrative market for normal balloon catheter.
Sales of normal balloon catheter in Asia-Pacific excluding Japan (APEJ) will
register the highest CAGR through 2022. In contrast, sales of normal balloon
catheter in North America will exhibit the lowest CAGR in the market through
2022. By indication, coronary artery disease will remain dominant in the global
market, with sales poised to surpass US$ 1,000 Mn in revenues by 2022-end.
Approximately three-fourth revenue share of the market will be accounted by
sales of normal balloon catheter for coronary artery disease during 2017 to
2022.
Sales of normal balloon catheter
in cardiac catheterization laboratories are expected to exhibit the fastest
expansion through 2022, based on end-users. Hospitals will remain the largest
end-users of normal balloon catheter throughout the forecast period. Nylon will
continue to be the preferred raw material for manufacturing normal balloon
catheter. Nearly half revenue share of the market will be accounted by nylon,
based on raw material. However, sales of polyurethane for production of normal
balloon catheter will register a comparatively higher CAGR than sales of nylon
through 2022.
Ask
Industry Experts about this Report - https://www.factmr.com/connectus/sample?flag=AE&rep_id=147
Normal Balloon Catheter Market: Competition Tracking
Key players profiled in FactMR’s
report include Abbott Laboratories, Boston Scientific Corporation, Medtronic
plc, Terumo Corporation, MicroPort Scientific Corporation, B. Braun Melsungen
AG, Meril Life Sciences Pvt. Ltd., Hexacath, Tokai Medical Products Inc., Cook
Medical INC, Cordis Corporation, and BIOTRONIK SE & Co. KG.
Comments
Post a Comment